CCB International lowered the target price for Ali Health (00241) to HKD4.2 from HKD6.3 and maintained the "outperform" rating.
The research house said it lowers FY24F top line forecast by 16.4% but increases adjusted net profit forecast by 96.8% to account for higher interest income and net profit contribution from the Alimama acquisition.
全新節目《說說心理話》青少年不可以戀愛！？真實個案講述驚心動魄經歷► 即睇
